Jack Dorsey: Square Will Go Further With Bitcoin Than Buy/Sell Option
Jack Dorsey, CEO of San Francisco-based payment service , revealed the company’s plans to focus on developing increased options for (BTC) use in a conference call Tuesday, Feb. 27 with .
Dorsey, who is also the CEO of Twitter, specifically discussed the company’s , which now allows all users to buy and sell bitcoin, telling Market Watch:
“bitcoin, for us, is not stopping at buying and selling. We do believe that this is a transformational technology for our industry, and we want to learn as quickly as possible.”
According to Square’s 2017 Q4 , also published Feb. 27, the company’s total net revenue and adjusted revenue have significantly increased compared to Q3 of 2017. Specifically regarding bitcoin use in Square’s Cash App, the report stated positively:
“Additionally, customers can now buy and sell bitcoin in Cash App. We observed that this was a feature our customers wanted, and we support bitcoin because we see it as a step in the long-term path toward greater financial access for all.”
, Cash App allows its users to carry out instant fiat transactions, free cash-outs, and instant bitcoin buy/sell option, which was for a limited part of users in November, 2017. , Square released the bitcoin buy/sell option to almost all users.
Earlier today, reported that Chase released an annual report for 2017 to the US (SEC) yesterday, Feb. 27, in which the company lists cryptocurrency as a “risk factor” for its future business.
¿Cómo usar Blockchain? | Oportunidades de Negocio para tu empresa 💡 En este ENLACE podrás tener acceso al CLUB EMPRENDE ▶︎ https://goo.gl/yB573M ¿Conoces la tecnología Blockchain? Este sistema está permitiendo que las redes de información, […]
Startup company has been working with university researchers to create a platform on the blockchain where patients can discuss their medical data with an advanced artificial intelligence “doctor.”
On August 24, doc.ai that their advanced natural language processing technology platform, based on the blockchain, would timestamp datasets and decentralize artificial intelligence. The startup stated that the platform was “envisioned and built” by researchers from Stanford and Cambridge Universities.
The objective of the company is to help healthcare companies improve patient care and experience through an advanced natural dialogue system which will be able to generate insights from combined medical data.
According to the World Health Organization, there is a shortage of seven million healthcare professionals globally, and that number is on the rise. There is increasing pressure on doctors who are faced with meeting the challenging needs of the population and keeping up with the latest developments in healthcare and medicine. Furthermore, the training of healthcare professionals takes years of education and experience. With the help of AI, doc.ai aims to address such challenges while improving the patient care and providing a better healthcare experience.
“We are making it possible for lab tests to converse directly with patients by leveraging advanced artificial intelligence, medical data forensics, and the decentralized blockchain. We envision extensive possibilities for the use of this technology by doctors, patients, and medical institutions,” Walter De Brouwer, founder and chief executive officer of doc.ai, said in a statement.
Deloitte Life Sciences and Healthcare is working with doc.ai to test the company’s Robo-hematology solution, which was developed recently at the Deloitte University in Dallas, Texas.
“doc.ai’s AI-based doctors provide answers to health questions using an AI-powered platform. Platforms like these open new possibilities for patients and medical organizations by providing more personalized, intelligent healthcare. We are excited to collaborate with doc.ai and to be at the forefront of this technology,” said Rajeev Ronanki, Principal of Life Sciences and Health Care at Deloitte Consulting LLP.
The platform operates as a Software as a Service (SaaS), providing service to medical companies, which will allow their patients to have personalized AI-powered conversations about their health around the clock. The conversations are personalized, based on the patient’s health data via a mobile app. The company expects to roll out three natural language processing modules — Robo-genomics, Robo-hematology and Robo-anatomics — for their clients.
Patients can ask the AI questions related to their health, such as “What should be my optimal Ferritin value based on my iron storage deficiency?” or “How can I decrease my cholesterol in the next 3 weeks?” or “Why was my glucose level over 100 and a week later it is at 93?”
According to doc.ai, the artificial intelligence will be able to provide answers for the patients with additional context for each answer. Furthermore, patients can communicate with the “AI-powered robo-doctor” to “achieve better health outcomes” from consultations with the patient’s physician.
